2023 annual financial data
MiNK Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -22,921,105 USD and net income was -22,457,859 USD.
Operating cash flow was -15,762,512 USD.
Get free MiNK Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,921,105 USD
- Net income
- -22,457,859 USD
- Operating cash flow
- -15,762,512 USD